Home / Share Price Target / Natcopharm
NATCO Pharma Share Price Target 2024, 2025, 2026 to 2039 With Charts
NATCO Pharma Limited | |||
 | Symbol: NATCOPHARM | ||
| Price: ₹1,376.55 | |||
| Exchange: NSE | |||
| Healthcare -> Drug Manufacturers - Specialty & Generic | |||
Show Table of Contents
Table of Contents
- 1: NATCO Pharma Brief Company Overview
- 1.1: NATCO Pharma Limited: A Comprehensive Overview
- 1.2: NATCO Pharma Financial Performance
- 1.2.1: Is NATCO Pharma A Good Buy For Long Term?
- 2: Approach 1: Technical Analysis Paired With Price Action
- 2.1: NATCO Pharma Share Price Target For 2024
- 2.1.1: NATCO Pharma Share Price Target Table For 2024
- 2.1.2: Summary: NATCO Pharma Share Price Prediction For 2024
- 2.2: NATCO Pharma Share Price Target For 2025
- 2.2.1: NATCO Pharma Share Price Target Table For 2025
- 2.2.2: Summary: NATCO Pharma Share Price Prediction For 2025
- 3: Approach 2: Machine Learning By Studying Historical Prices
- 3.1: NATCO Pharma Long Term Share Price Prediction Chart From 2024, 2025, 2026 to 2039
- 3.2: NATCO Pharma Share Price Target Table From 2024, 2025, 2026 to 2039
- 4: NATCO Pharma Past Performance
NATCO Pharma Brief Company Overview
NATCO Pharma Limited: A Comprehensive Overview
NATCO Pharma Limited, established in 1981, is a renowned pharmaceutical company headquartered in Hyderabad, India. The company has made a significant mark in the industry with its diverse product portfolio and global presence.
NATCO Pharma specializes in developing, manufacturing, and marketing finished dosage formulations and active pharmaceutical ingredients (APIs). Their product offerings span various therapeutic areas, including oncology, central nervous system, pain management, gastroenterology, cardiology, and diabetology.
The company also caters to the agricultural sector with its agrochemicals and biological pest management solutions, providing comprehensive crop protection across a range of crops.
NATCO Pharma's commitment to quality and innovation has earned them a reputation for excellence in the healthcare industry. They market their products in approximately 50 countries, demonstrating their strong global presence.
Advertisement
NATCO Pharma Financial Performance
| Metric | Value | Description |
|---|---|---|
| Market Capital | 25,602.81 Crore | Market valuation of NATCO Pharma's shares. |
| Revenue (TTM) | 4,349 Crore | Total revenue generated by NATCO Pharma over the past twelve months. |
| Net Income (TTM) | +1,636.49 Crore | Net Profit or Loss after all the expenses over the past twelve months. |
| Operating Margin | 55.82% | Income from operations as a percentage of revenue, before taxes and interest. |
| Profit Margin | 37.62% | Net income as a percentage of revenue, after all expenses. |
| Revenue Growth (Quarterly) | +19.5% | Change in revenue compared to the previous quarter. |
| Earnings Growth (YOY Quarterly) | +59.09% | Change in earnings compared to the same quarter last year. |
| Debt-to-Equity (D/E) Ratio | 6.34 | Company's total debt divided by total shareholder equity. |
| Total Debt | 371.2 Crore | Sum of NATCO Pharma's current & long-term financial obligations. |
| Total Cash | 1,849.2 Crore | Total amount of liquid funds available to NATCO Pharma. |
| Beta | 0.51 | Beta is less than 1 indicating that the NATCO Pharma's price is less volatile than the market. |
Is NATCO Pharma A Good Buy For Long Term?
No valid response content found
To predict the NATCO Pharma's future market prices, we harnessed 2 dynamic approaches:
Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices
Approach 1: Technical Analysis Paired With Price Action
NATCO Pharma Share Price Target For 2024
The line chart displays the monthly closing prices of NATCO Pharma with a black line. The green line shows three potential target prices for 2024, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for NATCO Pharma shares in 2024, see the table below.
Advertisement
NATCO Pharma Share Price Target Table For 2024
| NATCO Pharma's Levels | Value | Reason/Importance |
|---|---|---|
| 2024 Target 3 | 1421.17 (+3.24%) | Custom Fibonacci Extension Lvl 82% |
| 2024 Target 2 | 1402.90 (+1.91%) | Price Action: Sep 2024 Low |
| 2024 Target 1 | 1386.09 (+0.69%) | Price Action: 16 Oct 2024 Low |
| Current Price | 1376.55 | NATCO Pharma's 1 share price as of Thu 14 Nov 2024 |
| Stop Loss 1 | 1372.59 (-0.29%) | Price Action: Nov 2024 Low |
| Stop Loss 2 | 1357.25 (-1.41%) | Fibonacci Retracement Extended 28.2% |
| Stop Loss 3 | 1343.00 (-2.44%) | Price Action: Jul 2024 Low |
Summary: NATCO Pharma Share Price Prediction For 2024
In summary, NATCO Pharma has surged by ₹565.20, achieving a notable +69.66% increase from 1st January 2024 to 14 Nov 2024. Our analysis of NATCO Pharma for 2024 predicts an additional rise of 0.69% to 3.24% by the end of 2024 with three potential targets T1: 1386.09, T2: 1402.90, T3: 1421.17. Stop Loss at SL1: 1372.59, SL2: 1357.25, SL3: 1343.00.
NATCO Pharma has a 52-week high of ₹1639.00, acting as a crucial resistance level - a ceiling that could challenge further price increase. Conversely, it has a 52-week low of ₹752.45, a critical support level - think of this as a safety net where the price might stop falling.
After looking at 2024's share price prediction, let's now check what 2025 might hold for NATCO Pharma.
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
NATCO Pharma Share Price Target For 2025
The line chart displays the monthly closing prices of NATCO Pharma with a black line. The green line shows three potential target prices for 2025, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for NATCO Pharma shares in 2025, see the table below.
Advertisement
NATCO Pharma Share Price Target Table For 2025
| NATCO Pharma's Levels | Value | Reason/Importance |
|---|---|---|
| 2025 Target 3 | 1992.75 (+44.76%) | Fibonacci Extension Level 150% |
| 2025 Target 2 | 1944.66 (+41.27%) | Price Action: Chart |
| 2025 Target 1 | 1925.41 (+39.87%) | Custom Fibonacci Extension Lvl 64.9% |
| Current Price | 1376.55 | NATCO Pharma's 1 share price as of Thu 14 Nov 2024 |
| Stop Loss 1 | 1188.95 (-13.63%) | Price Action: May 2021 High |
| Stop Loss 2 | 1174.90 (-14.65%) | Price Action: Jun 2024 High |
| Stop Loss 3 | 1153.75 (-16.19%) | Price Action: Chart |
Summary: NATCO Pharma Share Price Prediction For 2025
In summary, NATCO Pharma has surged by ₹565.20, achieving a notable +69.66% increase from 1st January 2024 to 14 Nov 2024. Our analysis of NATCO Pharma for 2025 predicts an additional rise of 39.87% to 44.76% by the end of 2025 with three potential targets T1: 1925.41, T2: 1944.66, T3: 1992.75. Stop Loss at SL1: 1188.95, SL2: 1174.90, SL3: 1153.75.
NATCO Pharma has a All-Time high of ₹1639.00, acting as a crucial resistance level - a ceiling that could challenge further price increase. Conversely, it has a 52-week low of ₹752.45, a critical support level - think of this as a safety net where the price might stop falling.
After looking at 2024's and 2025's share price prediction, you might wonder what are short term targets for NATCO Pharma, we have created a specific page for that check here: NATCO Pharma Share Price Target For Tomorrow & Next Week
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Approach 2: Machine Learning By Studying Historical Prices
NATCO Pharma Long Term Share Price Prediction Chart From 2024, 2025, 2026 to 2039
This chart presents a detailed projection of NATCO Pharma share price predictions from 2024, 2025, 2026 to 2039. This share price Prediction represents a CAGR of 13.02% over the next 15 years.
For complete year by year NATCO Pharma long term share price target from 2024, 2025 to 2039 check the below table.
NATCO Pharma Share Price Target Table From 2024, 2025, 2026 to 2039
| Year | NATCO Pharma Target | YoY Change % |
|---|---|---|
| 2024 | ₹1,376.55 | [Current Price] |
| 2024 | ₹1,478.47 | 7.4% |
| 2025 | ₹2,075.94 | 40.41% |
| 2026 | ₹2,359.73 | 13.67% |
| 2027 | ₹2,648.49 | 12.23% |
| 2028 | ₹3,228.72 | 21.9% |
| 2029 | ₹3,707.95 | 14.84% |
| 2030 | ₹4,481.03 | 20.84% |
| 2031 | ₹4,579.34 | 2.19% |
| 2032 | ₹4,745.24 | 3.62% |
| 2033 | ₹5,435.43 | 14.54% |
| 2034 | ₹5,937.43 | 9.23% |
| 2035 | ₹6,886.13 | 15.97% |
| 2036 | ₹6,798.93 | -1.27% |
| 2037 | ₹6,841.98 | 0.63% |
| 2038 | ₹7,642.13 | 11.69% |
| 2039 | ₹8,204.91 | 7.36% |
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
NATCO Pharma Past Performance
- In 1995, NATCO Pharma opening price was ₹32
- As of Thu 14 Nov 2024 the price stands at ₹1,376.55.
- This represents a Compound Annual Growth Rate (CAGR) of 13.36%.
- In 29 years, an investment of 10,000 would have become ₹4.3 Lakh.
As we wrap up, we hope you like our study on NATCO Pharma share price predictions, please kindly note that these forecasts are based on technical analysis, past trends, and machine learning models. They are for educational purposes only, not investment advice.
Show Methodology We Use
Methodology Behind the Prediction
The share price predictions present on our site are derived from a robust model that incorporates multiple economic indicators, technical indicators, company performance metrics, and industry-specific factors.
We have historical share price data of all stocks for which we present targets, so we analyse historical trends from those past data and overlay them with projected market conditions to estimate future share prices of a stock.
- NATCO Pharma Share Price History
- NATCO Pharma Price Target Tomorrow
- NATCO Pharma Dividend History
- NATCO Pharma Split History
Disclaimer: Information is provided 'as is' and solely for informational and educational purposes, not for trading purposes or advice. We highly recommend to do your own research before making any investment.
